Literature DB >> 29136549

The spectrum of Charcot-Marie-Tooth disease due to myelin protein zero: An electrodiagnostic, nerve ultrasound and histological study.

Gian Maria Fabrizi1, Stefano Tamburin2, Tiziana Cavallaro3, Ilaria Cabrini1, Moreno Ferrarini1, Federica Taioli1, Francesca Magrinelli1, Giampietro Zanette4.   

Abstract

OBJECTIVE: Nerve ultrasound (US) data on myelin protein zero (MPZ)-related Charcot-Marie-Tooth disease (CMT) are lacking. To offer a comprehensive perspective on MPZ-related CMTs, we combined nerve US with clinics, electrodiagnosis and histopathology.
METHODS: We recruited 36 patients (12 MPZ mutations), and correlated nerve US to clinical, electrodiagnostic measures, and sural nerve biopsy.
RESULTS: According to motor nerve conduction velocity (MNCV) criteria, nine patients were categorized as "demyelinating" CMT1B, 17 as "axonal" CMT2I/J, and 10 as dominant "intermediate" CMTDID. Sural nerve biopsy showed hypertrophic de-remyelinating neuropathy with numerous complex onion bulbs in one patient, de-remyelinating neuropathy with scanty/absent onion bulbs in three, axonal neuropathy in two, mixed demyelinating-axonal neuropathy in five. Electrodiagnosis significantly differed in CMT1B vs. CMT2I/J and CMTDID subgroups. CMT1B had slightly enlarged nerve cross sectional area (CSA) especially at proximal upper-limb (UL) sites. CSA was negatively correlated to UL MNCV and not increased at entrapment sites. Major sural nerve pathological patterns were uncorrelated to UL nerve US and MNCV.
CONCLUSIONS: Sural nerve biopsy confirmed the wide pathological spectrum of MPZ-CMT. UL nerve US identified two major patterns corresponding to the CMT1B and CMT2I/J-CMTDID subgroups. SIGNIFICANCE: Nerve US phenotype of MPZ-CMT diverged from those in other demyelinating peripheral neuropathies and may have diagnostic value.
Copyright © 2017 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Electrodiagnostic study; Genetics; Myelin protein zero (MPZ); Nerve biopsy; Nerve ultrasound; Stratification

Mesh:

Substances:

Year:  2017        PMID: 29136549     DOI: 10.1016/j.clinph.2017.09.117

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  5 in total

1.  CIDP, CMT1B, or CMT1B plus CIDP?

Authors:  Davide Cardellini; Giampietro Zanette; Federica Taioli; Laura Bertolasi; Sergio Ferrari; Tiziana Cavallaro; Gian Maria Fabrizi
Journal:  Neurol Sci       Date:  2020-10-18       Impact factor: 3.307

Review 2.  Sustained response to subcutaneous immunoglobulins in chronic ataxic neuropathy with anti-disialosyl IgM antibodies (CANDA): report of two cases and review of the literature.

Authors:  D Marastoni; L Africa; G M Fabrizi; F Giannini; A Peretti; S Bocci; L Insana; S Ferrari; F Ginanneschi; G Zanette
Journal:  J Neurol       Date:  2020-04-28       Impact factor: 4.849

Review 3.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

4.  Proteome profile of peripheral myelin in healthy mice and in a neuropathy model.

Authors:  Sophie B Siems; Olaf Jahn; Maria A Eichel; Nirmal Kannaiyan; Lai Man N Wu; Diane L Sherman; Kathrin Kusch; Dörte Hesse; Ramona B Jung; Robert Fledrich; Michael W Sereda; Moritz J Rossner; Peter J Brophy; Hauke B Werner
Journal:  Elife       Date:  2020-03-04       Impact factor: 8.140

5.  Acute to Subacute Atraumatic Entrapment Neuropathies in Patients With CMT1A: A Report of a Distinct Phenotypic Variant of CMT1A.

Authors:  Zhiyong Chen; Monica Saini; Shermyn X M Neo; Peng-Soon Ng; Jasmine S Koh; Kalpana Prasad; Kamal Verma; Sonia Davila; Weng Khong Lim; Ziqun Phua; Michelle M Li; Corrine Kang; Karine S S Tay; Josiah Y H Chai
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.